{ "cik": 1099800, "cik_padded": "0001099800", "entityName": "Edwards Lifesciences Corp", "fiscal_years": [ { "accn": "0001099800-26-000009", "filed": "2026-02-25", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 893400000.0, "capex": 260200000.0, "cash": 2938000000.0, "cost_of_revenue": 1334200000.0, "eps_diluted": 1.83, "free_cash_flow": 1335000000.0, "gross_profit": 4733400000.0, "net_income": 1073500000.0, "operating_cash_flow": 1595200000.0, "operating_income": 1264200000.0, "revenue": 6067600000.0, "stockholders_equity": 10337600000.0, "total_assets": 13697200000.0, "total_liabilities": 3359600000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7801107521919705, "leverage": 0.32498839188980033, "net_margin": 0.17692333047662998, "operating_margin": 0.20835256114443934, "revenue_growth_yoy": 0.11547017189079879, "roa_avg2y": 0.08025418185216335, "roa_period_end": 0.07837368221242298, "roe_avg2y": 0.10557631785995279, "roe_period_end": 0.10384421916112058 } }, { "accn": "0001099800-26-000009", "filed": "2026-02-25", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1159400000.0, "capex": 252400000.0, "cash": 3045200000.0, "cost_of_revenue": 1117500000.0, "eps_diluted": 6.97, "free_cash_flow": 289900000.0, "gross_profit": 4322000000.0, "net_income": 4174600000.0, "operating_cash_flow": 542300000.0, "operating_income": 1378700000.0, "revenue": 5439500000.0, "stockholders_equity": 9998400000.0, "total_assets": 13055300000.0, "total_liabilities": 2992400000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7945583233753102, "leverage": 0.29928788606176987, "net_margin": 0.7674602445077673, "operating_margin": 0.2534607960290468, "revenue_growth_yoy": 0.08572854291417166, "roa_avg2y": 0.3724245600731539, "roa_period_end": 0.3197628549324795, "roe_avg2y": 0.501501645803801, "roe_period_end": 0.4175268042886862 } }, { "accn": "0001099800-26-000009", "filed": "2026-02-25", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 879600000.0, "capex": 253000000.0, "cash": 1132300000.0, "cost_of_revenue": 978400000.0, "eps_diluted": 2.3, "free_cash_flow": 642800000.0, "gross_profit": 4031600000.0, "net_income": 1402400000.0, "operating_cash_flow": 895800000.0, "operating_income": 1308900000.0, "revenue": 5010000000.0, "stockholders_equity": 6650000000.0, "total_assets": 9363200000.0, "total_liabilities": 2643800000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8047105788423153, "leverage": 0.39756390977443606, "net_margin": 0.2799201596806387, "operating_margin": 0.2612574850299401, "revenue_growth_yoy": 0.12231182795698925, "roa_avg2y": 0.1588608777901754, "roa_period_end": 0.14977785372522215, "roe_avg2y": 0.22516396798510038, "roe_period_end": 0.2108872180451128 } }, { "accn": "0001099800-25-000005", "filed": "2025-02-28", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1727100000.0, "capex": 244600000.0, "cash": 769000000.0, "cost_of_revenue": 723700000.0, "eps_diluted": 2.44, "free_cash_flow": 973600000.0, "gross_profit": 3740300000.0, "net_income": 1521900000.0, "operating_cash_flow": 1218200000.0, "operating_income": 1498400000.0, "revenue": 4464000000.0, "stockholders_equity": 5806700000.0, "total_assets": 8292500000.0, "total_liabilities": 2485800000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8378808243727599, "leverage": 0.4280916871889369, "net_margin": 0.3409274193548387, "operating_margin": 0.335663082437276, "revenue_growth_yoy": -0.14687052078356427, "roa_avg2y": 0.18123143059582855, "roa_period_end": 0.1835272836900814, "roe_avg2y": 0.261436448903166, "roe_period_end": 0.262093788210171 } }, { "accn": "0001099800-24-000004", "filed": "2024-02-12", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 512800000.0, "capex": 325800000.0, "cash": 862800000.0, "cost_of_revenue": 1248900000.0, "eps_diluted": 2.38, "free_cash_flow": 1406300000.0, "gross_profit": 3983600000.0, "net_income": 1503100000.0, "operating_cash_flow": 1732100000.0, "operating_income": 1690300000.0, "revenue": 5232500000.0, "stockholders_equity": 5835900000.0, "total_assets": 8502600000.0, "total_liabilities": 2666700000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7613186813186813, "leverage": 0.4569475145221817, "net_margin": 0.28726230291447685, "operating_margin": 0.3230387004300048, "revenue_growth_yoy": 0.19291886099901967, "roa_avg2y": 0.19099474577024975, "roa_period_end": 0.1767812198621598, "roe_avg2y": 0.28877447119171584, "roe_period_end": 0.25756095889237307 } }, { "accn": "0001099800-23-000005", "filed": "2023-02-13", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 625400000.0, "capex": 407000000.0, "cash": 1183200000.0, "cost_of_revenue": 1080600000.0, "eps_diluted": 1.3, "free_cash_flow": 647300000.0, "gross_profit": 3305700000.0, "operating_cash_flow": 1054300000.0, "operating_income": 897600000.0, "revenue": 4386300000.0, "stockholders_equity": 4574300000.0, "total_assets": 7237100000.0, "total_liabilities": 2662800000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "gross_margin": 0.7536420217495383, "leverage": 0.5821218547100103, "operating_margin": 0.20463716572053894, "revenue_growth_yoy": 0.008808647654093836 } }, { "accn": "0001099800-23-000005", "filed": "2023-02-13", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 263300000.0, "capex": 254400000.0, "cash": 1179100000.0, "cost_of_revenue": 1114400000.0, "eps_diluted": 1.64, "free_cash_flow": 928500000.0, "gross_profit": 3233600000.0, "operating_cash_flow": 1182900000.0, "operating_income": 1146800000.0, "revenue": 4348000000.0, "stockholders_equity": 4148300000.0, "total_assets": 6488100000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "gross_margin": 0.7436982520699172, "operating_margin": 0.2637534498620055, "revenue_growth_yoy": 0.16793811109917267 } }, { "accn": "0001099800-22-000005", "filed": "2022-02-14", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 795500000.0, "capex": 238700000.0, "cash": 714100000.0, "cost_of_revenue": 939400000.0, "eps_diluted": 1.13, "free_cash_flow": 688000000.0, "gross_profit": 2783400000.0, "operating_cash_flow": 926700000.0, "operating_income": 748200000.0, "revenue": 3722800000.0, "stockholders_equity": 3140400000.0, "total_assets": 5323700000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "gross_margin": 0.7476630493177179, "operating_margin": 0.20097775867626522, "revenue_growth_yoy": 0.08368992518848427 } }, { "accn": "0001099800-21-000007", "filed": "2021-02-12", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 763300000.0, "capex": 168100000.0, "cash": 818300000.0, "cost_of_revenue": 875300000.0, "eps_diluted": 2.7, "free_cash_flow": 832600000.0, "gross_profit": 2560000000.0, "operating_cash_flow": 1000700000.0, "operating_income": 1089400000.0, "revenue": 3435300000.0, "stockholders_equity": 2956200000.0, "total_assets": 5666400000.0 }, "period_end": "2017-12-31", "ratio_units": { "gross_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "gross_margin": 0.7452042034174599, "operating_margin": 0.3171193200011644, "revenue_growth_yoy": 0.15912541755238385 } }, { "accn": "0001099800-20-000005", "filed": "2020-02-14", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 662300000.0, "capex": 176100000.0, "cash": 930100000.0, "cost_of_revenue": 797400000.0, "eps_diluted": 2.61, "free_cash_flow": 528300000.0, "gross_profit": 2166300000.0, "operating_cash_flow": 704400000.0, "operating_income": 751200000.0, "revenue": 2963700000.0, "stockholders_equity": 2619000000.0, "total_assets": 4510000000.0 }, "period_end": "2016-12-31", "ratio_units": { "gross_margin": "ratio", "operating_margin": "ratio" }, "ratios": { "gross_margin": 0.7309444275736411, "operating_margin": 0.2534669500961636 } } ], "latest_filing": { "accn": "0001099800-26-000009", "filed": "2026-02-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3842", "sic_description": "Orthopedic, Prosthetic & Surgical Appliances & Supplies", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001099800.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001099800.json" }, "ticker": "EW" }